Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. (1st March 2021)
- Record Type:
- Journal Article
- Title:
- Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. (1st March 2021)
- Main Title:
- Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency
- Authors:
- Kuriwaki, Ikumi
Kameda, Minoru
Iikubo, Kazuhiko
Hisamichi, Hiroyuki
Kawamoto, Yuichiro
Kikuchi, Shigetoshi
Moritomo, Hiroyuki
Kondoh, Yutaka
Terasaka, Tadashi
Amano, Yasushi
Tateishi, Yukihiro
Echizen, Yuka
Iwai, Yoshinori
Noda, Atsushi
Tomiyama, Hiroshi
Nakazawa, Taisuke
Hirano, Masaaki - Abstract:
- Graphical abstract: Abstract: Fibroblast growth factor receptor 3 (FGFR3) is an attractive therapeutic target for the treatment of patients with bladder cancer harboring genetic alterations in FGFR3. We identified pyrimidine derivative 20b, which induced tumor regression following oral administration to a bladder cancer xenograft mouse model. Compound 20b was discovered by optimizing lead compound 1, which we reported previously. Specifically, reducing the molecular size of the substituent at the 4-position and replacing the linker of the 5-position in the pyrimidine scaffold resulted in an increase in systemic exposure. Furthermore, introduction of two fluorine atoms into the 3, 5-dimethoxyphenyl ring enhanced FGFR3 inhibitory activity. Molecular dynamics (MD) simulation of 20b suggested that the fluorine atom interacts with the main chain NH moiety of Asp635 via a hydrogen bond.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 33(2021)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 33(2021)
- Issue Display:
- Volume 33, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 33
- Issue:
- 2021
- Issue Sort Value:
- 2021-0033-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-03-01
- Subjects:
- Fibroblast growth factor receptor 3 -- Bladder cancer -- Antitumor effect -- X-ray crystal structure -- Molecular dynamics simulation -- Structure–activity relationships
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2021.116019 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15802.xml